Weld Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,097	Closed	-$792K	–	852
2019 Q1	$792K	Buy	+10,097	New	+$792K	0.14%	270